Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

ITCIITCI
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in INTRA-CELLULAR THERAPIES INC

BlackRock Finance, Inc. holds 6.3M shares of ITCI (INTRA-CELLULAR THERAPIES INC), worth $433M as of 2024-Q2. The position was decreased (-21.7% shares). ITCI represents 0.0% of BlackRock Finance, Inc.'s portfolio.

Current Value

$433M

Current Shares

6.3M

Total Value Change

-$153.9M

Total Shares Change

-1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Decreased
6.3M
-21.7%
$433M0.0%—
0
2024-Q1
Decreased
8.1M
-1.4%
$559M0.0%—
0
2023-Q4
New
8.2M
-
$586.8M0.0%—
44

Other major holders of ITCI: VANGUARD GROUP INC, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used